Novetide

Company Overview

Snapshot

Founded in January 1999, Novetide operates with 11–50 employees.

Business overview

Novetide specializes in the development and manufacture of commercially available peptide products, maintaining a robust pipeline of products in development. Leveraging proprietary technologies, the company focuses on peptide production through sequence assembly, downstream processing, characterization, and documentation of peptide drug substances. With two FDA-approved production sites, Novetide offers flexible and scalable manufacturing capabilities, supplying peptides to multinational pharmaceutical companies, startups, and researchers globally. The company operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology, and Drugs Discovery & Development.

Company Intelligence Q&A

What is Novetide's primary focus?

Novetide specializes in the development and manufacture of commercially available peptide products, utilizing proprietary technologies for sequence assembly, downstream processing, characterization, and documentation of peptide drug substances.

When was Novetide founded?

Novetide was founded in January 1999.

What are some of the products manufactured by Novetide?

Novetide manufactures peptide products including Eptifibatide, Desmopressin acetate, Octreotide acetate, Teriparatide acetate, Atosiban acetate, and Bivalirudin.

What is the employee count for Novetide?

Novetide operates with 11–50 employees.